

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.34743367 |
| 2 | central nervous system myelination (GO:0022010) | 7.34743367 |
| 3 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.73291836 |
| 4 | fatty acid elongation (GO:0030497) | 4.54191251 |
| 5 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.47332243 |
| 6 | cullin deneddylation (GO:0010388) | 4.27419439 |
| 7 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.25989737 |
| 8 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.24488746 |
| 9 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.21198424 |
| 10 | cytochrome complex assembly (GO:0017004) | 4.18445471 |
| 11 | protein deneddylation (GO:0000338) | 4.17379622 |
| 12 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.03271288 |
| 13 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.02835243 |
| 14 | regulation of mitochondrial translation (GO:0070129) | 3.97281753 |
| 15 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.91154714 |
| 16 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.91154714 |
| 17 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.89439433 |
| 18 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.89439433 |
| 19 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.89439433 |
| 20 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.89137537 |
| 21 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.89110531 |
| 22 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.89110531 |
| 23 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.87362776 |
| 24 | negative regulation of ligase activity (GO:0051352) | 3.87362776 |
| 25 | myelin maintenance (GO:0043217) | 3.79790394 |
| 26 | myelination (GO:0042552) | 3.78843261 |
| 27 | negative regulation of protein localization to cell surface (GO:2000009) | 3.76809988 |
| 28 | axon ensheathment (GO:0008366) | 3.75787441 |
| 29 | ensheathment of neurons (GO:0007272) | 3.75787441 |
| 30 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.70175193 |
| 31 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.70175193 |
| 32 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.68788649 |
| 33 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.67830675 |
| 34 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.66389697 |
| 35 | platelet dense granule organization (GO:0060155) | 3.62079298 |
| 36 | protein targeting to mitochondrion (GO:0006626) | 3.58931257 |
| 37 | ubiquinone biosynthetic process (GO:0006744) | 3.55981053 |
| 38 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.54134340 |
| 39 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.53961862 |
| 40 | termination of RNA polymerase III transcription (GO:0006386) | 3.51948758 |
| 41 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.51948758 |
| 42 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.51421884 |
| 43 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.47293423 |
| 44 | oxidative phosphorylation (GO:0006119) | 3.46757711 |
| 45 | photoreceptor cell differentiation (GO:0046530) | 3.40450733 |
| 46 | eye photoreceptor cell differentiation (GO:0001754) | 3.40450733 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.38512726 |
| 48 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.38413653 |
| 49 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.38413653 |
| 50 | purine nucleotide salvage (GO:0032261) | 3.36876438 |
| 51 | substantia nigra development (GO:0021762) | 3.36591853 |
| 52 | protein localization to mitochondrion (GO:0070585) | 3.35648723 |
| 53 | establishment of protein localization to mitochondrion (GO:0072655) | 3.34233343 |
| 54 | inner mitochondrial membrane organization (GO:0007007) | 3.32999032 |
| 55 | positive regulation of ligase activity (GO:0051351) | 3.32501350 |
| 56 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.29634162 |
| 57 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.28135528 |
| 58 | deoxyribonucleotide catabolic process (GO:0009264) | 3.27582545 |
| 59 | branched-chain amino acid catabolic process (GO:0009083) | 3.25953053 |
| 60 | creatine metabolic process (GO:0006600) | 3.25264573 |
| 61 | daunorubicin metabolic process (GO:0044597) | 3.24288672 |
| 62 | polyketide metabolic process (GO:0030638) | 3.24288672 |
| 63 | doxorubicin metabolic process (GO:0044598) | 3.24288672 |
| 64 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.22921031 |
| 65 | positive regulation of mitochondrial fission (GO:0090141) | 3.21611265 |
| 66 | phagocytosis, engulfment (GO:0006911) | 3.21320474 |
| 67 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.17823185 |
| 68 | deoxyribose phosphate catabolic process (GO:0046386) | 3.15926254 |
| 69 | ubiquinone metabolic process (GO:0006743) | 3.15785593 |
| 70 | oligodendrocyte differentiation (GO:0048709) | 3.13127716 |
| 71 | base-excision repair, AP site formation (GO:0006285) | 3.12180410 |
| 72 | regulation of cellular amine metabolic process (GO:0033238) | 3.11495604 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10193555 |
| 74 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.08996180 |
| 75 | virion attachment to host cell (GO:0019062) | 3.08935065 |
| 76 | adhesion of symbiont to host cell (GO:0044650) | 3.08935065 |
| 77 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.08614420 |
| 78 | enteric nervous system development (GO:0048484) | 3.07902776 |
| 79 | deoxyribose phosphate metabolic process (GO:0019692) | 3.07645508 |
| 80 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.07565990 |
| 81 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.07531493 |
| 82 | ATP synthesis coupled proton transport (GO:0015986) | 3.03960587 |
| 83 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.03960587 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.03933605 |
| 85 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.02643320 |
| 86 | respiratory electron transport chain (GO:0022904) | 3.02198039 |
| 87 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 3.00421466 |
| 88 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.99106828 |
| 89 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.97952250 |
| 90 | regulation of collateral sprouting (GO:0048670) | 2.97148847 |
| 91 | L-amino acid import (GO:0043092) | 2.96324295 |
| 92 | ATP biosynthetic process (GO:0006754) | 2.95928220 |
| 93 | electron transport chain (GO:0022900) | 2.95357456 |
| 94 | hydrogen ion transmembrane transport (GO:1902600) | 2.94992165 |
| 95 | sequestering of actin monomers (GO:0042989) | 2.94069925 |
| 96 | amino acid salvage (GO:0043102) | 2.93520511 |
| 97 | L-methionine salvage (GO:0071267) | 2.93520511 |
| 98 | L-methionine biosynthetic process (GO:0071265) | 2.93520511 |
| 99 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.93369391 |
| 100 | mitochondrial transport (GO:0006839) | 2.93084227 |
| 101 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.91210225 |
| 102 | deoxyribonucleotide metabolic process (GO:0009262) | 2.89913193 |
| 103 | DNA deamination (GO:0045006) | 2.88668942 |
| 104 | membrane raft organization (GO:0031579) | 2.88480012 |
| 105 | regulation of ligase activity (GO:0051340) | 2.87677738 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.86432343 |
| 107 | protein complex biogenesis (GO:0070271) | 2.85710299 |
| 108 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.85559324 |
| 109 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.84638777 |
| 110 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.83469648 |
| 111 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.83469648 |
| 112 | NADH dehydrogenase complex assembly (GO:0010257) | 2.83469648 |
| 113 | positive regulation of cell cycle arrest (GO:0071158) | 2.83126103 |
| 114 | peptidyl-histidine modification (GO:0018202) | 2.82879486 |
| 115 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.82702574 |
| 116 | purine-containing compound salvage (GO:0043101) | 2.82464328 |
| 117 | regulation of relaxation of muscle (GO:1901077) | 2.80063417 |
| 118 | GPI anchor biosynthetic process (GO:0006506) | 2.79979822 |
| 119 | C-terminal protein amino acid modification (GO:0018410) | 2.79544847 |
| 120 | dermatan sulfate metabolic process (GO:0030205) | 2.78957214 |
| 121 | intracellular protein transmembrane import (GO:0044743) | 2.78611409 |
| 122 | dermatan sulfate biosynthetic process (GO:0030208) | 2.73887324 |
| 123 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.72748150 |
| 124 | amyloid precursor protein metabolic process (GO:0042982) | 2.72616780 |
| 125 | proteasome assembly (GO:0043248) | 2.69679497 |
| 126 | extracellular fibril organization (GO:0043206) | 2.69276955 |
| 127 | mannosylation (GO:0097502) | 2.69164725 |
| 128 | cholesterol biosynthetic process (GO:0006695) | 2.67910195 |
| 129 | astrocyte development (GO:0014002) | 2.65116345 |
| 130 | amyloid precursor protein catabolic process (GO:0042987) | 2.64621793 |
| 131 | signal peptide processing (GO:0006465) | 2.62572381 |
| 132 | negative regulation of neurotransmitter transport (GO:0051589) | 2.60792806 |
| 133 | myelination in peripheral nervous system (GO:0022011) | 2.57857980 |
| 134 | peripheral nervous system axon ensheathment (GO:0032292) | 2.57857980 |
| 135 | peripheral nervous system neuron development (GO:0048935) | 2.55834894 |
| 136 | neutrophil activation involved in immune response (GO:0002283) | 2.50297304 |
| 137 | blood vessel maturation (GO:0001955) | 2.50008976 |
| 138 | glial cell development (GO:0021782) | 2.49803370 |
| 139 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.49532289 |
| 140 | sterol biosynthetic process (GO:0016126) | 2.48719656 |
| 141 | fibril organization (GO:0097435) | 2.47632420 |
| 142 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.46485503 |
| 143 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.46485503 |
| 144 | regulation of somitogenesis (GO:0014807) | 2.44312207 |
| 145 | regulation of metalloenzyme activity (GO:0048552) | 2.43908344 |
| 146 | response to redox state (GO:0051775) | 2.42344743 |
| 147 | response to muscle activity (GO:0014850) | 2.41584046 |
| 148 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.40388072 |
| 149 | protein neddylation (GO:0045116) | 2.39822677 |
| 150 | chaperone-mediated protein transport (GO:0072321) | 2.39444822 |
| 151 | intracellular pH reduction (GO:0051452) | 2.39206687 |
| 152 | GPI anchor metabolic process (GO:0006505) | 2.39164467 |
| 153 | neurotransmitter uptake (GO:0001504) | 2.38900358 |
| 154 | axoneme assembly (GO:0035082) | 2.38677917 |
| 155 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.38378096 |
| 156 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.38378096 |
| 157 | nuclear envelope reassembly (GO:0031468) | 2.36318235 |
| 158 | mitotic nuclear envelope reassembly (GO:0007084) | 2.36318235 |
| 159 | lateral sprouting from an epithelium (GO:0060601) | 2.35110853 |
| 160 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.34705455 |
| 161 | metallo-sulfur cluster assembly (GO:0031163) | 2.32991434 |
| 162 | iron-sulfur cluster assembly (GO:0016226) | 2.32991434 |
| 163 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.32804779 |
| 164 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.32804779 |
| 165 | Golgi to plasma membrane protein transport (GO:0043001) | 2.32441857 |
| 166 | axon development (GO:0061564) | 2.32136456 |
| 167 | mitochondrion degradation (GO:0000422) | 2.31318165 |
| 168 | amino acid import (GO:0043090) | 2.31085627 |
| 169 | C-terminal protein lipidation (GO:0006501) | 2.30932411 |
| 170 | response to methylmercury (GO:0051597) | 2.30895689 |
| 171 | positive regulation of vasculogenesis (GO:2001214) | 2.30233776 |
| 172 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.28351613 |
| 173 | respiratory chain complex IV assembly (GO:0008535) | 2.25339533 |
| 174 | GTP biosynthetic process (GO:0006183) | 2.25006140 |
| 175 | import into cell (GO:0098657) | 2.24495028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.86127599 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.90483299 |
| 3 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.48996741 |
| 4 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.18131186 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.81434736 |
| 6 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.81056445 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.56918329 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.54135721 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.49287587 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.43312383 |
| 11 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.41284165 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.41258258 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.38464056 |
| 14 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.38417567 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.30097895 |
| 16 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.26443857 |
| 17 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.24057489 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23856748 |
| 19 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10493322 |
| 20 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05348342 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05313670 |
| 22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.96536697 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.89682959 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.88641454 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.87736380 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.85679934 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.83661251 |
| 28 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.80122402 |
| 29 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.79817470 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.76568914 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75068093 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74505877 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.74243527 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71826631 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.71096209 |
| 36 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.68909414 |
| 37 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.66492704 |
| 38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.62393652 |
| 39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.60644334 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58752821 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57402472 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55084725 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54629881 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54629881 |
| 45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53669289 |
| 46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.52394522 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52271803 |
| 48 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.51586584 |
| 49 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.50807370 |
| 50 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49721672 |
| 51 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.49415803 |
| 52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.48423889 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45808119 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45595875 |
| 55 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45566895 |
| 56 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.43483089 |
| 57 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.42991640 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39843684 |
| 59 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36321418 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35496195 |
| 61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31765956 |
| 62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31394418 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26039296 |
| 64 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.25137347 |
| 65 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.24201547 |
| 66 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23133767 |
| 67 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.23109916 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23007479 |
| 69 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.22231789 |
| 70 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22197050 |
| 71 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.21829901 |
| 72 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.21587022 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.21385388 |
| 74 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20518034 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19327293 |
| 76 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19091808 |
| 77 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.18401347 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.17795727 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.17471867 |
| 80 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.15033708 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14982991 |
| 82 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.14092831 |
| 83 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.13643872 |
| 84 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13238353 |
| 85 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12156442 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11677664 |
| 87 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11613414 |
| 88 | NFI_21473784_ChIP-Seq_ESCs_Mouse | 1.09832103 |
| 89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08916926 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.07671145 |
| 91 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07207125 |
| 92 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.07167429 |
| 93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06661983 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06505556 |
| 95 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.06485378 |
| 96 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06153201 |
| 97 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04640685 |
| 98 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03697428 |
| 99 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.03592312 |
| 100 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02943254 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.02367261 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02320207 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.01497479 |
| 104 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00699780 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.00212560 |
| 106 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.00075773 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.98225246 |
| 108 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97835886 |
| 109 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97708688 |
| 110 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97569151 |
| 111 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.96824223 |
| 112 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.96055382 |
| 113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96036459 |
| 114 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94525993 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94081773 |
| 116 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93833754 |
| 117 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93701264 |
| 118 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93665025 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93633642 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93601092 |
| 121 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.93309389 |
| 122 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92941201 |
| 123 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92386329 |
| 124 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91781911 |
| 125 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91778087 |
| 126 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.91620025 |
| 127 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.91354193 |
| 128 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90479027 |
| 129 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90163672 |
| 130 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90079735 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89878590 |
| 132 | EWS_26573619_Chip-Seq_HEK293_Human | 0.89767797 |
| 133 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89264392 |
| 134 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.89005547 |
| 135 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87725563 |
| 136 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87725563 |
| 137 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87216429 |
| 138 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.87020850 |
| 139 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86958385 |
| 140 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86688191 |
| 141 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86620710 |
| 142 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86049436 |
| 143 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85565940 |
| 144 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84661821 |
| 145 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.84436636 |
| 146 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.84436636 |
| 147 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.84293201 |
| 148 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.83982406 |
| 149 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83552369 |
| 150 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.83518800 |
| 151 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83306303 |
| 152 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.83259454 |
| 153 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83223306 |
| 154 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82907287 |
| 155 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82484075 |
| 156 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82313329 |
| 157 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.81958700 |
| 158 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81849390 |
| 159 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.81564022 |
| 160 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.80790370 |
| 161 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.79110911 |
| 162 | VDR_22108803_ChIP-Seq_LS180_Human | 0.78584825 |
| 163 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77994154 |
| 164 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.77833371 |
| 165 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.76179144 |
| 166 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.76083998 |
| 167 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.75220553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.97951264 |
| 2 | MP0000920_abnormal_myelination | 3.41782694 |
| 3 | MP0002102_abnormal_ear_morphology | 3.35561056 |
| 4 | MP0008058_abnormal_DNA_repair | 3.26450827 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.97497471 |
| 6 | MP0000749_muscle_degeneration | 2.71592558 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.70204968 |
| 8 | MP0003011_delayed_dark_adaptation | 2.49543915 |
| 9 | MP0006035_abnormal_mitochondrial_morpho | 2.46058234 |
| 10 | MP0008789_abnormal_olfactory_epithelium | 2.39530818 |
| 11 | MP0003718_maternal_effect | 2.19278730 |
| 12 | MP0003724_increased_susceptibility_to | 2.15026509 |
| 13 | MP0001958_emphysema | 2.12494056 |
| 14 | MP0003279_aneurysm | 2.06619646 |
| 15 | MP0002736_abnormal_nociception_after | 2.06181089 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.04025109 |
| 17 | MP0006072_abnormal_retinal_apoptosis | 2.03310088 |
| 18 | MP0000747_muscle_weakness | 2.02406197 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.00567779 |
| 20 | MP0009697_abnormal_copulation | 1.95418070 |
| 21 | MP0005275_abnormal_skin_tensile | 1.91712407 |
| 22 | MP0005503_abnormal_tendon_morphology | 1.88878441 |
| 23 | MP0003690_abnormal_glial_cell | 1.88779300 |
| 24 | MP0001905_abnormal_dopamine_level | 1.88737444 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.84447930 |
| 26 | MP0001529_abnormal_vocalization | 1.76682028 |
| 27 | MP0002933_joint_inflammation | 1.74982861 |
| 28 | MP0003634_abnormal_glial_cell | 1.72861798 |
| 29 | MP0004145_abnormal_muscle_electrophysio | 1.72271346 |
| 30 | MP0004147_increased_porphyrin_level | 1.70848410 |
| 31 | MP0000751_myopathy | 1.70731623 |
| 32 | MP0003329_amyloid_beta_deposits | 1.69653808 |
| 33 | MP0002653_abnormal_ependyma_morphology | 1.69057724 |
| 34 | MP0003786_premature_aging | 1.68554500 |
| 35 | MP0005171_absent_coat_pigmentation | 1.68254079 |
| 36 | MP0004142_abnormal_muscle_tone | 1.66514406 |
| 37 | MP0000358_abnormal_cell_content/ | 1.65205142 |
| 38 | MP0009384_cardiac_valve_regurgitation | 1.63814254 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.63339904 |
| 40 | MP0010094_abnormal_chromosome_stability | 1.62334587 |
| 41 | MP0001986_abnormal_taste_sensitivity | 1.62087128 |
| 42 | MP0008007_abnormal_cellular_replicative | 1.59818673 |
| 43 | MP0001542_abnormal_bone_strength | 1.57721977 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.54622546 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.54596284 |
| 46 | MP0000343_altered_response_to | 1.54157490 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.51475111 |
| 48 | MP0003136_yellow_coat_color | 1.51089475 |
| 49 | MP0000685_abnormal_immune_system | 1.47342737 |
| 50 | MP0000516_abnormal_urinary_system | 1.43605415 |
| 51 | MP0005367_renal/urinary_system_phenotyp | 1.43605415 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.38052012 |
| 53 | MP0002090_abnormal_vision | 1.37782547 |
| 54 | MP0008932_abnormal_embryonic_tissue | 1.36625102 |
| 55 | MP0008569_lethality_at_weaning | 1.34372403 |
| 56 | MP0001835_abnormal_antigen_presentation | 1.33218286 |
| 57 | MP0005671_abnormal_response_to | 1.30360173 |
| 58 | MP0003646_muscle_fatigue | 1.29167152 |
| 59 | MP0001764_abnormal_homeostasis | 1.28377140 |
| 60 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27185413 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.26756556 |
| 62 | MP0005499_abnormal_olfactory_system | 1.26756556 |
| 63 | MP0009785_altered_susceptibility_to | 1.25538865 |
| 64 | MP0008260_abnormal_autophagy | 1.24430759 |
| 65 | MP0002822_catalepsy | 1.20296737 |
| 66 | MP0003186_abnormal_redox_activity | 1.15557140 |
| 67 | MP0002108_abnormal_muscle_morphology | 1.13406340 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.12864161 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.12055164 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.11844696 |
| 71 | MP0003077_abnormal_cell_cycle | 1.11502016 |
| 72 | MP0009250_abnormal_appendicular_skeleto | 1.11484756 |
| 73 | MP0005408_hypopigmentation | 1.11139281 |
| 74 | MP0005165_increased_susceptibility_to | 1.09507023 |
| 75 | MP0004084_abnormal_cardiac_muscle | 1.08894746 |
| 76 | MP0002163_abnormal_gland_morphology | 1.08474138 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.07975628 |
| 78 | MP0001348_abnormal_lacrimal_gland | 1.07733036 |
| 79 | MP0005369_muscle_phenotype | 1.06974462 |
| 80 | MP0004215_abnormal_myocardial_fiber | 1.06367694 |
| 81 | MP0001851_eye_inflammation | 1.05380440 |
| 82 | MP0006054_spinal_hemorrhage | 1.04150103 |
| 83 | MP0001346_abnormal_lacrimal_gland | 1.03976596 |
| 84 | MP0005646_abnormal_pituitary_gland | 1.03693907 |
| 85 | MP0008872_abnormal_physiological_respon | 1.02757540 |
| 86 | MP0001661_extended_life_span | 1.01853063 |
| 87 | MP0008877_abnormal_DNA_methylation | 1.01505051 |
| 88 | MP0005332_abnormal_amino_acid | 1.01359868 |
| 89 | MP0006276_abnormal_autonomic_nervous | 1.01326886 |
| 90 | MP0001299_abnormal_eye_distance/ | 1.01136943 |
| 91 | MP0001984_abnormal_olfaction | 1.00878398 |
| 92 | MP0002234_abnormal_pharynx_morphology | 1.00563556 |
| 93 | MP0002106_abnormal_muscle_physiology | 1.00117026 |
| 94 | MP0004381_abnormal_hair_follicle | 0.99380830 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.99063915 |
| 96 | MP0002419_abnormal_innate_immunity | 0.98163101 |
| 97 | MP0005330_cardiomyopathy | 0.97792163 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.96606862 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.95865308 |
| 100 | MP0000049_abnormal_middle_ear | 0.95644905 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.95220930 |
| 102 | MP0000759_abnormal_skeletal_muscle | 0.94310503 |
| 103 | MP0005025_abnormal_response_to | 0.93329289 |
| 104 | MP0009046_muscle_twitch | 0.92947851 |
| 105 | MP0002972_abnormal_cardiac_muscle | 0.92529549 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.92263509 |
| 107 | MP0004134_abnormal_chest_morphology | 0.91096415 |
| 108 | MP0006036_abnormal_mitochondrial_physio | 0.90813542 |
| 109 | MP0005508_abnormal_skeleton_morphology | 0.90350159 |
| 110 | MP0000604_amyloidosis | 0.90209915 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.90118446 |
| 112 | MP0002938_white_spotting | 0.90083330 |
| 113 | MP0005620_abnormal_muscle_contractility | 0.88273061 |
| 114 | MP0001324_abnormal_eye_pigmentation | 0.88061746 |
| 115 | MP0002160_abnormal_reproductive_system | 0.88026693 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.87995131 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.87959184 |
| 118 | MP0001485_abnormal_pinna_reflex | 0.87872550 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.87333103 |
| 120 | MP0005410_abnormal_fertilization | 0.87061841 |
| 121 | MP0006292_abnormal_olfactory_placode | 0.86957399 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.86831713 |
| 123 | MP0001486_abnormal_startle_reflex | 0.86218154 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.84428112 |
| 125 | MP0001929_abnormal_gametogenesis | 0.84376443 |
| 126 | MP0002272_abnormal_nervous_system | 0.83483704 |
| 127 | MP0002229_neurodegeneration | 0.82643271 |
| 128 | MP0003111_abnormal_nucleus_morphology | 0.82367304 |
| 129 | MP0002210_abnormal_sex_determination | 0.82128350 |
| 130 | MP0001533_abnormal_skeleton_physiology | 0.81014205 |
| 131 | MP0005253_abnormal_eye_physiology | 0.80844143 |
| 132 | MP0002751_abnormal_autonomic_nervous | 0.79867234 |
| 133 | MP0001293_anophthalmia | 0.79654336 |
| 134 | MP0003880_abnormal_central_pattern | 0.79472654 |
| 135 | MP0004087_abnormal_muscle_fiber | 0.79460348 |
| 136 | MP0001853_heart_inflammation | 0.79094355 |
| 137 | MP0003075_altered_response_to | 0.78116224 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.77437933 |
| 139 | MP0005390_skeleton_phenotype | 0.77390998 |
| 140 | MP0009764_decreased_sensitivity_to | 0.76911251 |
| 141 | MP0002723_abnormal_immune_serum | 0.76683543 |
| 142 | MP0004885_abnormal_endolymph | 0.76464823 |
| 143 | MP0004130_abnormal_muscle_cell | 0.75905012 |
| 144 | MP0003633_abnormal_nervous_system | 0.75891484 |
| 145 | MP0005319_abnormal_enzyme/_coenzyme | 0.75709490 |
| 146 | MP0005645_abnormal_hypothalamus_physiol | 0.75501338 |
| 147 | MP0000653_abnormal_sex_gland | 0.74217685 |
| 148 | MP0005075_abnormal_melanosome_morpholog | 0.73911569 |
| 149 | MP0002282_abnormal_trachea_morphology | 0.73512674 |
| 150 | MP0002735_abnormal_chemical_nociception | 0.73386205 |
| 151 | MP0005174_abnormal_tail_pigmentation | 0.72998237 |
| 152 | MP0005266_abnormal_metabolism | 0.72812543 |
| 153 | MP0000681_abnormal_thyroid_gland | 0.72439555 |
| 154 | MP0000750_abnormal_muscle_regeneration | 0.71858652 |
| 155 | MP0005389_reproductive_system_phenotype | 0.71710099 |
| 156 | MP0000647_abnormal_sebaceous_gland | 0.71693737 |
| 157 | MP0003656_abnormal_erythrocyte_physiolo | 0.71643173 |
| 158 | MP0004133_heterotaxia | 0.69625732 |
| 159 | MP0004742_abnormal_vestibular_system | 0.69309504 |
| 160 | MP0001119_abnormal_female_reproductive | 0.67868733 |
| 161 | MP0003195_calcinosis | 0.67383142 |
| 162 | MP0005670_abnormal_white_adipose | 0.67196197 |
| 163 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66679888 |
| 164 | MP0008873_increased_physiological_sensi | 0.64686936 |
| 165 | MP0001145_abnormal_male_reproductive | 0.64035326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Retinal dysplasia (HP:0007973) | 3.70357196 |
| 2 | Hepatocellular necrosis (HP:0001404) | 3.69351153 |
| 3 | Increased hepatocellular lipid droplets (HP:0006565) | 3.67551646 |
| 4 | Cerebral edema (HP:0002181) | 3.66111179 |
| 5 | Lipid accumulation in hepatocytes (HP:0006561) | 3.66102544 |
| 6 | Acute necrotizing encephalopathy (HP:0006965) | 3.45168314 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.29320668 |
| 8 | Increased serum lactate (HP:0002151) | 3.27792585 |
| 9 | Mitochondrial inheritance (HP:0001427) | 3.16810989 |
| 10 | Hepatic necrosis (HP:0002605) | 3.05554993 |
| 11 | Nemaline bodies (HP:0003798) | 3.00505497 |
| 12 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.95530402 |
| 13 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.94888235 |
| 14 | Neurofibrillary tangles (HP:0002185) | 2.90391331 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88418183 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 2.86306661 |
| 17 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.84568594 |
| 18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.84568594 |
| 19 | Muscle fiber inclusion bodies (HP:0100299) | 2.81884615 |
| 20 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.81331597 |
| 21 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.79862912 |
| 22 | Hyperglycinemia (HP:0002154) | 2.74312379 |
| 23 | Dicarboxylic aciduria (HP:0003215) | 2.72608337 |
| 24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72608337 |
| 25 | Lethargy (HP:0001254) | 2.72221652 |
| 26 | Progressive macrocephaly (HP:0004481) | 2.70161994 |
| 27 | CNS demyelination (HP:0007305) | 2.66079092 |
| 28 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.65670503 |
| 29 | Patchy hypopigmentation of hair (HP:0011365) | 2.64921895 |
| 30 | Humeroradial synostosis (HP:0003041) | 2.64768024 |
| 31 | Synostosis involving the elbow (HP:0003938) | 2.64768024 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.63114580 |
| 33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.63114580 |
| 34 | Progressive neurologic deterioration (HP:0002344) | 2.62477469 |
| 35 | Cerebral hypomyelination (HP:0006808) | 2.60450621 |
| 36 | Distal arthrogryposis (HP:0005684) | 2.59326963 |
| 37 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.54494428 |
| 38 | Megalencephaly (HP:0001355) | 2.53451125 |
| 39 | Leukodystrophy (HP:0002415) | 2.53099624 |
| 40 | Acute encephalopathy (HP:0006846) | 2.50510735 |
| 41 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.49341534 |
| 42 | Aplasia of the phalanges of the hand (HP:0009802) | 2.49341534 |
| 43 | Aplasia involving bones of the extremities (HP:0009825) | 2.49341534 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 2.48094489 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 2.48094489 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.47861436 |
| 47 | Increased CSF lactate (HP:0002490) | 2.47785044 |
| 48 | Peripheral hypomyelination (HP:0007182) | 2.43184314 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.39992079 |
| 50 | Pancreatic cysts (HP:0001737) | 2.38763150 |
| 51 | White forelock (HP:0002211) | 2.38632155 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.38495743 |
| 53 | Exertional dyspnea (HP:0002875) | 2.35526760 |
| 54 | Neuroendocrine neoplasm (HP:0100634) | 2.34535551 |
| 55 | Parakeratosis (HP:0001036) | 2.32873587 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30206531 |
| 57 | Pancreatic fibrosis (HP:0100732) | 2.29997819 |
| 58 | Methylmalonic aciduria (HP:0012120) | 2.29685142 |
| 59 | Degeneration of anterior horn cells (HP:0002398) | 2.29179152 |
| 60 | Abnormality of the anterior horn cell (HP:0006802) | 2.29179152 |
| 61 | Ragged-red muscle fibers (HP:0003200) | 2.28742266 |
| 62 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.28521302 |
| 63 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.26110779 |
| 64 | Pheochromocytoma (HP:0002666) | 2.23101985 |
| 65 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.22598351 |
| 66 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.22598351 |
| 67 | Abnormal protein glycosylation (HP:0012346) | 2.22598351 |
| 68 | Abnormal glycosylation (HP:0012345) | 2.22598351 |
| 69 | Calf muscle hypertrophy (HP:0008981) | 2.20813710 |
| 70 | Clumsiness (HP:0002312) | 2.20573626 |
| 71 | Hypothermia (HP:0002045) | 2.19866823 |
| 72 | Vertebral compression fractures (HP:0002953) | 2.19563835 |
| 73 | Emotional lability (HP:0000712) | 2.18892951 |
| 74 | Pulmonary artery stenosis (HP:0004415) | 2.18829942 |
| 75 | Microvesicular hepatic steatosis (HP:0001414) | 2.17388864 |
| 76 | Progressive microcephaly (HP:0000253) | 2.14862331 |
| 77 | Exercise intolerance (HP:0003546) | 2.12957989 |
| 78 | True hermaphroditism (HP:0010459) | 2.12573456 |
| 79 | Loss of speech (HP:0002371) | 2.12263252 |
| 80 | Respiratory failure (HP:0002878) | 2.09600518 |
| 81 | Abnormality of glycolysis (HP:0004366) | 2.09389008 |
| 82 | Increased serum pyruvate (HP:0003542) | 2.09389008 |
| 83 | Exercise-induced muscle cramps (HP:0003710) | 2.09147146 |
| 84 | Nonprogressive disorder (HP:0003680) | 2.08166645 |
| 85 | Opisthotonus (HP:0002179) | 2.05742420 |
| 86 | Poor speech (HP:0002465) | 2.04767843 |
| 87 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.04586477 |
| 88 | Round ear (HP:0100830) | 2.04475847 |
| 89 | Exercise-induced myalgia (HP:0003738) | 2.04455965 |
| 90 | Pancytopenia (HP:0001876) | 2.01398495 |
| 91 | Muscle fiber splitting (HP:0003555) | 2.01202127 |
| 92 | Spastic paraparesis (HP:0002313) | 2.00860593 |
| 93 | Gowers sign (HP:0003391) | 1.98430890 |
| 94 | Hyperglycinuria (HP:0003108) | 1.97907094 |
| 95 | Methylmalonic acidemia (HP:0002912) | 1.97571760 |
| 96 | Split foot (HP:0001839) | 1.97514615 |
| 97 | Abnormality of the columella (HP:0009929) | 1.97263873 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.95739788 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 1.94060259 |
| 100 | Absent septum pellucidum (HP:0001331) | 1.93567964 |
| 101 | Medial flaring of the eyebrow (HP:0010747) | 1.93098877 |
| 102 | Hepatosplenomegaly (HP:0001433) | 1.90857297 |
| 103 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.90791265 |
| 104 | Dysostosis multiplex (HP:0000943) | 1.90518550 |
| 105 | Onion bulb formation (HP:0003383) | 1.90029268 |
| 106 | Congenital primary aphakia (HP:0007707) | 1.89262944 |
| 107 | Bile duct proliferation (HP:0001408) | 1.89035713 |
| 108 | Abnormal biliary tract physiology (HP:0012439) | 1.89035713 |
| 109 | Abnormality of glycine metabolism (HP:0010895) | 1.88796964 |
| 110 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88796964 |
| 111 | Lactic acidosis (HP:0003128) | 1.88639123 |
| 112 | Petechiae (HP:0000967) | 1.88549123 |
| 113 | Testicular atrophy (HP:0000029) | 1.87800966 |
| 114 | Ankle clonus (HP:0011448) | 1.86760639 |
| 115 | Rhabdomyolysis (HP:0003201) | 1.86677364 |
| 116 | Progressive inability to walk (HP:0002505) | 1.86327531 |
| 117 | Renal Fanconi syndrome (HP:0001994) | 1.85912171 |
| 118 | Type 2 muscle fiber atrophy (HP:0003554) | 1.84913199 |
| 119 | Ketoacidosis (HP:0001993) | 1.84898727 |
| 120 | EMG: myopathic abnormalities (HP:0003458) | 1.84680549 |
| 121 | Renal cortical cysts (HP:0000803) | 1.84550412 |
| 122 | Increased muscle lipid content (HP:0009058) | 1.83373770 |
| 123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83302501 |
| 124 | Abnormality of alanine metabolism (HP:0010916) | 1.83302501 |
| 125 | Hyperalaninemia (HP:0003348) | 1.83302501 |
| 126 | X-linked dominant inheritance (HP:0001423) | 1.82926143 |
| 127 | Optic disc pallor (HP:0000543) | 1.82523982 |
| 128 | Poor head control (HP:0002421) | 1.82035468 |
| 129 | Ketosis (HP:0001946) | 1.81220677 |
| 130 | Bell-shaped thorax (HP:0001591) | 1.81190941 |
| 131 | Abnormality of glycolipid metabolism (HP:0010969) | 1.80301608 |
| 132 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.80301608 |
| 133 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.80301608 |
| 134 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80243536 |
| 135 | Vacuolated lymphocytes (HP:0001922) | 1.80057815 |
| 136 | Chronic otitis media (HP:0000389) | 1.80026908 |
| 137 | Abnormality of macrophages (HP:0004311) | 1.79743907 |
| 138 | Recurrent abscess formation (HP:0002722) | 1.79017130 |
| 139 | Gait imbalance (HP:0002141) | 1.78335868 |
| 140 | Hypokinesia (HP:0002375) | 1.78045639 |
| 141 | Nephrogenic diabetes insipidus (HP:0009806) | 1.77778669 |
| 142 | Abnormality of renal resorption (HP:0011038) | 1.76930193 |
| 143 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.76611746 |
| 144 | Short tibia (HP:0005736) | 1.75703178 |
| 145 | CNS hypomyelination (HP:0003429) | 1.75690840 |
| 146 | Prolonged neonatal jaundice (HP:0006579) | 1.75510147 |
| 147 | Muscle fiber atrophy (HP:0100295) | 1.75223635 |
| 148 | Calcaneovalgus deformity (HP:0001848) | 1.74925094 |
| 149 | Hypoglycemic coma (HP:0001325) | 1.73263941 |
| 150 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.73214296 |
| 151 | Abnormality of the calf musculature (HP:0001430) | 1.72873505 |
| 152 | Sclerocornea (HP:0000647) | 1.72602978 |
| 153 | Neck muscle weakness (HP:0000467) | 1.72579907 |
| 154 | Median cleft lip (HP:0000161) | 1.71916883 |
| 155 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.71391501 |
| 156 | Neoplasm of the adrenal gland (HP:0100631) | 1.69355640 |
| 157 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.69166995 |
| 158 | Hyperammonemia (HP:0001987) | 1.67249906 |
| 159 | Abnormality of urine glucose concentration (HP:0011016) | 1.66937107 |
| 160 | Glycosuria (HP:0003076) | 1.66937107 |
| 161 | Cholecystitis (HP:0001082) | 1.65883972 |
| 162 | Abnormal gallbladder physiology (HP:0012438) | 1.65883972 |
| 163 | Blindness (HP:0000618) | 1.65696056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 4.25587200 |
| 2 | MUSK | 3.55656979 |
| 3 | MAP4K2 | 3.44128004 |
| 4 | LIMK1 | 3.17844964 |
| 5 | CAMKK2 | 3.08226198 |
| 6 | STK39 | 3.05089076 |
| 7 | MAPKAPK5 | 3.00582814 |
| 8 | TNIK | 2.68591129 |
| 9 | ZAK | 2.43826777 |
| 10 | TRIM28 | 2.37321814 |
| 11 | BLK | 2.34056246 |
| 12 | CDK19 | 2.22402267 |
| 13 | ARAF | 2.17514946 |
| 14 | NUAK1 | 2.13443992 |
| 15 | PIM2 | 2.12167842 |
| 16 | PBK | 2.02023354 |
| 17 | STK16 | 1.95810533 |
| 18 | PHKG1 | 1.94039764 |
| 19 | PHKG2 | 1.94039764 |
| 20 | EIF2AK1 | 1.90636581 |
| 21 | NEK1 | 1.86187679 |
| 22 | MAP3K12 | 1.84144810 |
| 23 | TESK2 | 1.82101480 |
| 24 | KIT | 1.81896400 |
| 25 | MST4 | 1.79631753 |
| 26 | OXSR1 | 1.68150267 |
| 27 | LMTK2 | 1.64185764 |
| 28 | IRAK1 | 1.58863175 |
| 29 | IRAK4 | 1.56716025 |
| 30 | EPHB1 | 1.51948315 |
| 31 | CCNB1 | 1.49884556 |
| 32 | CDK8 | 1.49199231 |
| 33 | EIF2AK3 | 1.47805539 |
| 34 | BCR | 1.43768293 |
| 35 | SRPK1 | 1.41713950 |
| 36 | ERBB3 | 1.37685500 |
| 37 | PDK2 | 1.32979060 |
| 38 | MYLK | 1.32871312 |
| 39 | TEC | 1.31487311 |
| 40 | OBSCN | 1.30707883 |
| 41 | GRK1 | 1.29906733 |
| 42 | NEK9 | 1.29445830 |
| 43 | IRAK2 | 1.24528400 |
| 44 | ILK | 1.24016018 |
| 45 | MAP2K7 | 1.20212388 |
| 46 | TLK1 | 1.20119425 |
| 47 | PLK2 | 1.19205219 |
| 48 | ROCK2 | 1.18330414 |
| 49 | DAPK1 | 1.16217719 |
| 50 | ADRBK2 | 1.13495495 |
| 51 | PINK1 | 1.12502295 |
| 52 | CAMK1D | 1.08855734 |
| 53 | TBK1 | 1.06609535 |
| 54 | MAPKAPK3 | 1.06402487 |
| 55 | PLK3 | 1.06217289 |
| 56 | BMPR1B | 1.06128373 |
| 57 | ABL2 | 1.04398113 |
| 58 | KDR | 1.01230871 |
| 59 | CSNK1G3 | 0.99023955 |
| 60 | NME2 | 0.98836019 |
| 61 | TXK | 0.97830257 |
| 62 | WEE1 | 0.92367275 |
| 63 | PLK4 | 0.90540233 |
| 64 | BUB1 | 0.90398433 |
| 65 | DYRK3 | 0.90389070 |
| 66 | CSF1R | 0.89423680 |
| 67 | IRAK3 | 0.88987013 |
| 68 | NLK | 0.88733613 |
| 69 | INSRR | 0.88146007 |
| 70 | CAMK2D | 0.87831205 |
| 71 | WNK4 | 0.87163480 |
| 72 | TESK1 | 0.86773318 |
| 73 | DYRK2 | 0.86522797 |
| 74 | BCKDK | 0.85698143 |
| 75 | VRK1 | 0.85560417 |
| 76 | DMPK | 0.83504923 |
| 77 | WNK3 | 0.81785983 |
| 78 | PLK1 | 0.81451598 |
| 79 | MAP3K13 | 0.80967974 |
| 80 | NEK6 | 0.79932602 |
| 81 | MAPK13 | 0.77632090 |
| 82 | FRK | 0.77367286 |
| 83 | CDC7 | 0.77042987 |
| 84 | CAMK2G | 0.74965683 |
| 85 | PKN1 | 0.72827426 |
| 86 | AURKA | 0.70383878 |
| 87 | RAF1 | 0.70296535 |
| 88 | CSNK1G1 | 0.70176350 |
| 89 | GRK7 | 0.69664517 |
| 90 | MAP4K1 | 0.69145328 |
| 91 | BTK | 0.68079098 |
| 92 | GRK5 | 0.68039479 |
| 93 | CLK1 | 0.67164956 |
| 94 | ADRBK1 | 0.66779035 |
| 95 | ZAP70 | 0.64226406 |
| 96 | PRKCI | 0.64224627 |
| 97 | NTRK1 | 0.63803893 |
| 98 | SGK494 | 0.63544915 |
| 99 | SGK223 | 0.63544915 |
| 100 | CASK | 0.63526710 |
| 101 | MAP3K11 | 0.62464977 |
| 102 | SCYL2 | 0.62187089 |
| 103 | RPS6KA5 | 0.62044853 |
| 104 | TRIB3 | 0.61436741 |
| 105 | EPHA3 | 0.60882517 |
| 106 | IKBKE | 0.59632191 |
| 107 | CAMK2B | 0.59579365 |
| 108 | CSNK1G2 | 0.59059060 |
| 109 | MOS | 0.58559014 |
| 110 | CSNK1A1L | 0.57520857 |
| 111 | PRKD1 | 0.57260959 |
| 112 | SIK3 | 0.57038048 |
| 113 | AURKB | 0.56226239 |
| 114 | PRKCE | 0.54466764 |
| 115 | ROCK1 | 0.53323433 |
| 116 | MET | 0.53196932 |
| 117 | JAK3 | 0.52350741 |
| 118 | TRPM7 | 0.52147907 |
| 119 | PIK3CG | 0.51711166 |
| 120 | ATR | 0.51598657 |
| 121 | CDK14 | 0.51066710 |
| 122 | FGR | 0.50757319 |
| 123 | LCK | 0.50131684 |
| 124 | FLT3 | 0.49501271 |
| 125 | MAPK15 | 0.49262524 |
| 126 | CAMK1G | 0.48548305 |
| 127 | PRKCQ | 0.47874801 |
| 128 | MINK1 | 0.47133968 |
| 129 | EIF2AK2 | 0.46963046 |
| 130 | CSNK2A1 | 0.46816105 |
| 131 | BRAF | 0.46552892 |
| 132 | PRPF4B | 0.46521272 |
| 133 | DAPK3 | 0.46348909 |
| 134 | FES | 0.46092501 |
| 135 | YES1 | 0.45391010 |
| 136 | RPS6KA4 | 0.45166045 |
| 137 | PRKG2 | 0.45095151 |
| 138 | NME1 | 0.45026673 |
| 139 | BRSK1 | 0.44820082 |
| 140 | PIK3CA | 0.44499544 |
| 141 | MAPKAPK2 | 0.44014642 |
| 142 | LYN | 0.43923921 |
| 143 | TGFBR1 | 0.43102981 |
| 144 | PAK1 | 0.41982827 |
| 145 | MAP3K4 | 0.39411188 |
| 146 | CDK7 | 0.36204710 |
| 147 | EPHB2 | 0.35722541 |
| 148 | ACVR1B | 0.35555267 |
| 149 | TIE1 | 0.33772933 |
| 150 | PAK4 | 0.33662971 |
| 151 | TTK | 0.32244576 |
| 152 | PRKCG | 0.32112579 |
| 153 | MAP2K6 | 0.31983360 |
| 154 | CSNK2A2 | 0.31841343 |
| 155 | CDK9 | 0.29733816 |
| 156 | IKBKB | 0.29202653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.76188839 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.35737438 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.30987938 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.24763764 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.96423195 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.80759095 |
| 7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.53693663 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.46896767 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.43773644 |
| 10 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.31869463 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.30904117 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.06956068 |
| 13 | Mismatch repair_Homo sapiens_hsa03430 | 2.05145251 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.03449764 |
| 15 | Proteasome_Homo sapiens_hsa03050 | 2.03044355 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 1.98524212 |
| 17 | Huntingtons disease_Homo sapiens_hsa05016 | 1.89426761 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.89059473 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.87655410 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.86121013 |
| 21 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.84396639 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83670659 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75673178 |
| 24 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72626421 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68607517 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63883952 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.57375610 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52263722 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.48766515 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42193678 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.42057017 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.35992178 |
| 33 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.33924467 |
| 34 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.27707889 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.25825476 |
| 36 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24021512 |
| 37 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.23691987 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17058589 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.15522290 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15251812 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.14104306 |
| 42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.13829411 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.12815103 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11546155 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09971751 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05438200 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 1.05271823 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04287533 |
| 49 | Spliceosome_Homo sapiens_hsa03040 | 1.03122053 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02597492 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.02416865 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01165477 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 0.97737562 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96786683 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95253074 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.93766418 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.93546205 |
| 58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92223296 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89151324 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89143621 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89065622 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87986807 |
| 63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86064143 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86000909 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85008922 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84626541 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83036296 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82447970 |
| 69 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.78958396 |
| 70 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76850863 |
| 71 | RNA transport_Homo sapiens_hsa03013 | 0.76537366 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73840900 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70971014 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67226449 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.66769452 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66124004 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65054007 |
| 78 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63906233 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.62999420 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62751813 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62573119 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.62179293 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61852555 |
| 84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61502026 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61431485 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60156029 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59061480 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.58398987 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57480319 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57308374 |
| 91 | Allograft rejection_Homo sapiens_hsa05330 | 0.57132143 |
| 92 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56700652 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.56495575 |
| 94 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56394784 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.55281242 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54440493 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.52986049 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51411139 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50994860 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50850863 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50691035 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50041989 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49527955 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49437665 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49245192 |
| 106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48756446 |
| 107 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.48338448 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.48131903 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47104241 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46315062 |
| 111 | Homologous recombination_Homo sapiens_hsa03440 | 0.46055895 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45296972 |
| 113 | Tuberculosis_Homo sapiens_hsa05152 | 0.45063677 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45001674 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44912300 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44655316 |
| 117 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44339040 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44002483 |
| 119 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43363712 |
| 120 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42210936 |
| 121 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41278993 |
| 122 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40997693 |
| 123 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.40724439 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40588798 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.40097213 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37159438 |
| 127 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37120182 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37060416 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36110499 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.36100908 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.35093467 |
| 132 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34922163 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.34478375 |
| 134 | Peroxisome_Homo sapiens_hsa04146 | 0.34341527 |
| 135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.34176025 |
| 136 | Basal transcription factors_Homo sapiens_hsa03022 | 0.33646160 |
| 137 | Measles_Homo sapiens_hsa05162 | 0.33493378 |
| 138 | Asthma_Homo sapiens_hsa05310 | 0.33439019 |
| 139 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.32873973 |
| 140 | Cell cycle_Homo sapiens_hsa04110 | 0.32729461 |
| 141 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32400439 |
| 142 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31370631 |
| 143 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30069454 |
| 144 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29686442 |
| 145 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27948609 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27812867 |
| 147 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.26846420 |
| 148 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.24037460 |

